GLP-1s: Changing the Obesity Treatment Narrative The seismic shift in obesity treatment, propelled by these medications like Wegovy (Semaglutide) and Zepbound (Tirzepatide), has opened up new possibilities
Flavonoids are a broad group of secondary metabolites, recognized to possess a diverse range of biological activities, including antioxidant, anti-inflammatory, anti-diabetic and diabetes-related complications like diabetic neuropathy, anti-microbial, anti-cancer, neuroprotective, and cardioprotective-properties (Panche et al
Because of this (long) half-life, semaglutide is usually given as a once-weekly injection, which helps maintain a steady level in your system over time
Most GLP-1 medications are given via subcutaneous injection, which means an injection under the skin but not in the muscle
The whites have a high concentration of amino acids, including glutamine, and are high in protein but low in fat